Status:

COMPLETED

Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD)

Lead Sponsor:

Children's Hospital Medical Center, Cincinnati

Collaborating Sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Conditions:

Child Development Disorders, Pervasive

Eligibility:

All Genders

4-21 years

Phase:

PHASE1

PHASE2

Brief Summary

The purpose of this study is to determine if the known differences in genes influence drug metabolizing enzymes and receptors that are involved in risperidone drug action. The study will determine if ...

Detailed Description

To the knowledge of the investigators there are no studies documenting the pharmacokinetics and pharmacogenetics of risperidone in children with PDD. Currently the PPRU network is conducting a PK stud...

Eligibility Criteria

Inclusion

  • Male and female patients between the ages of 4 and 21 years.
  • Patients meeting DSM-IV criteria for autistic disorder, Pervasive Developmental Disorder (PDD), or Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS) and about to initiate clinical treatment or currently clinically treated with risperidone.
  • Patients about to initiate clinical treatment or currently clinically treated with risperidone, or currently on risperidone as a participant in one of the multi-site Research Unit for Pediatric Psychopharmacology (RUPP) protocols.

Exclusion

  • Children taking psychotropic or other medication that will significantly interact with target CYP 450 isoenzyme activity, such to the discretion of the principal investigator (PI).
  • Patients with known renal or hepatic dysfunction (e.g. serum creatinine, and transaminases or bilirubin exceeding age specific upper range limits) are not eligible.
  • Failure of the parent/legal guardian to give informed consent.

Key Trial Info

Start Date :

February 1 2003

Trial Type :

INTERVENTIONAL

End Date :

March 1 2005

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00166595

Start Date

February 1 2003

End Date

March 1 2005

Last Update

January 28 2014

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Children's Hospital of Michigan/Wayne State University

Detroit, Michigan, United States, 48201

2

Duke University Medical Center

Durham, North Carolina, United States, 27705

3

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States, 45229

4

The Ohio State University Medical Center

Columbus, Ohio, United States, 43210-1296